Koyfin Home > Directory > Health Care > Intellia Thera CS > Net Debt / (EBITDA-CAPEX)

Intellia Thera CS Net Debt / (EBITDA-CAPEX) Chart (NTLA)

Intellia Thera CS annual/quarterly Net Debt / (EBITDA-CAPEX) from 2014 to 2020.
  • Intellia Thera CS Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $3m a 13.31% increase of 0m year over year
  • Intellia Thera CS Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $4m a 15.95% increase of 1m year over year
  • Intellia Thera CS Annual Net Debt / (EBITDA-CAPEX) for 2019 was $3m a -24.52% decrease of -1m from 2018
  • Intellia Thera CS Annual Net Debt / (EBITDA-CAPEX) for 2018 was $3m a -31.28% decrease of -1m from 2017
  • Intellia Thera CS Annual Net Debt / (EBITDA-CAPEX) for 2017 was $4m a -65.07% decrease of -3m from 2016
Other Ratios Metrics:
  • Intellia Thera CS Other Liabilities for the quarter ending September 09, 2018 was $32m a -38.16% decrease of -12m year over year
View Chart On Koyfin

Quarterly NTLA Net Debt / (EBITDA-CAPEX) Data

06/2020$3m
03/2020$2m
12/2019$2m
09/2019$3m
06/2019$3m
03/2019$3m
12/2018$4m
09/2018$3m
06/2018$3m
03/2018$4m

Annual NTLA Net Debt / (EBITDA-CAPEX) Data

2019$3m
2018$3m
2017$4m
2016$7m
2015$5m
2014$2m